Dieses Anti-NCOA3-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von NCOA3 in WB und ELISA. Geeignet für Human. Dieses Primary Antibody wurde in 2+ Publikationen zitiert.
NCOA3
Reaktivität: Human
WB, ChIP
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA: 1/10000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
Ascitic fluid containing 0.03 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Pu, Ye, Spitz, Wang, Gu, Lippman, Hildebrandt, Hong, Minna, Roth, Yang, Wu: "Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 21, pp. 5983-91, (2012) (PubMed).
Bai, Wong: "Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach." in: Clinical chemistry, Vol. 50, Issue 6, pp. 996-1001, (2004) (PubMed).
Target
NCOA3
(Nuclear Receptor Coactivator 3 (NCOA3))
Andere Bezeichnung
AIB1
Hintergrund
The poly Q polymorphism in ,AIB1 ,(amplified in breast cancer) gene is usually assessed by fragment length analysis which does not reveal the actual sequence variation. The purpose of this study is to investigate the sequence variation of poly Q encoding region in breast cancer cell lines at single molecule level, and to determine if the sequence variation is related to ,AIB1 ,gene amplification.